About Us

The Cancer Letter, an independent weekly news publication, has been the leading source for information on the issues that shape oncology since 1973.

The Cancer Letter provides authoritative, award-winning coverage of the development of cancer therapies, drug regulation, legislation, cancer research funding, health care finance, and public health. Our coverage focuses on the National Cancer Institute, National Institutes of Health, Food & Drug Administration, U.S. Congress, cancer centers, and the pharmaceutical industry.

The Cancer Letter’s readers include key opinion leaders at academic institutions, community oncology practices, government agencies, professional associations, health IT and pharmaceutical companies, Wall Street, and advocacy organizations. Learn more about our readers.

Based in Washington, D.C., The Cancer Letter has earned acclaim for its investigative work. It has been profiled and cited in outlets including The New York Times, The Washington Post, 60 Minutes, CNN, NPR, Science, and Nature.

Coverage by The Cancer Letter has triggered multiple investigations by Congressional committees, the Institute of Medicine, the Federal Trade Commission, the Securities and Exchange Commission, and the Department of Justice, and contributed to federal action by the FDA, the Centers for Disease Control and Prevention, the Federal Bureau of Investigation, and Government Accountability Office.

The Cancer Letter was founded in 1973, two years after Congress passed the National Cancer Act of 1971.

Editorial Policies

  • The Cancer Letter provides fair and balanced coverage of events in oncology.
  • The Cancer Letter publisher and staff are prohibited from holding individual stock positions in healthcare, pharmaceutical, or biotechnology companies.



Paul Goldberg (paul@cancerletter.com) is the editor and publisher of The Cancer Letter. He joined the publication in 1986.

His coverage has had a profound impact on the field of oncology, leading to numerous Congressional investigations, and helped change policy, regulation, and standards of care.

Paul’s reporting has been recognized by the Washington DC Professional Chapter of the Society of Professional Journalists, the Gerald Loeb Awards, the Association of Health Care Journalists, and the Newsletter and Electronic Publishers Foundation.

His articles have appeared in The New York Times, The Wall Street Journal, The Washington Post and The Washington Monthly, and he has been featured on 60 Minutes, 20/20, CNN and NPR. He is also a novelist and author of nonfiction books. His author website is www.paulgoldberg.com

His books include:

Paul graduated from Duke University with a B.A. in economics in 1981.


Matthew Ong (matthew@cancerletter.com) is associate editor of The Cancer Letter. He joined the publication in 2012.

Matt’s reporting on the politics and business of cancer research and drug development have led to Congressional investigations, triggered action by FDA, CDC, FBI, and GAO, and helped change policy and standards of care.

His work has been recognized by the National Press Club, Society of Professional Journalists, Association of Health Care Journalists, The Poynter Institute, Society of American Business Editors and Writers, National Institute for Health Care Management Foundation, American Society of Business Publication Editors, American Association of University Professors, the Washington Media Institute, and Washington, DC Professional Chapter of the Society of Professional Journalists.

His stories have been picked up and cited in The Washington Post, The Wall Street Journal, The New York Review of Books, ABC News, CBS affiliates, The Boston Globe, Science, Nature, Inside Higher Ed, The Houston Chronicle, The Philadelphia Inquirer, The Journal of the American Medical Association, The British Medical Journal, The American Journal of Managed Care, and by the President’s Cancer Panel, CEO Roundtable on Cancer, CEO Cancer Life Sciences Consortium, and the American Association for Cancer Research. He has been interviewed on public radio programs, including NPR.

Matt was selected from over 130 journalists by The Poynter Institute and The Washington Post to join the 2020-21 Leadership Academy for Diversity in Digital Media. He was also chosen as a fellow for AHCJ’s inaugural 2016 class of the National Cancer Reporting Fellowships at the National Cancer Institute, and the 2017 Comparative Effectiveness Research Fellowship at the Patient-Centered Outcomes Research Institute. He serves as a guest speaker for AHCJ’s fellowships and annual Health Journalism conferences.

Matt graduated from Marquette University in 2012, majoring in journalism, psychology, as well as women’s and gender studies. His CV is available on www.matthewong.com.


alex headshotAlexandria Carolan (alex@cancerletter.com) is a reporter with The Cancer Letter. She joined the publication in 2019. 

Her work focuses on a wide range of oncology issues including appropriations, diversity and, most recently, gender-related bias. 

Alexandria has worked as an editorial associate at the American Society of Clinical Oncology, where she wrote for The ASCO Daily News, and edited ASCO Educational Book and meeting programs. Alexandria holds a B.A. in journalism and English from the University of Maryland (2018), where she wrote for the university’s independent student newspaper, The Diamondback. 

She has written for local newspapers and magazines, where she covered city affairs, crime, science and technology, and bias. Alex’s work has appeared in The Washington Post, The Associated Press, Capital News Service, Asbury Park Press, Bethesda Beat and Bethesda Magazine.


katie headshotKatie Goldberg (katie@cancerletter.com) is operations manager and illustrator at The Cancer Letter. She joined the publication full-time in 2018, and has been providing editorial illustrations since 2015.

Katie manages all operational and business development functions of The Cancer Letter, including subscription services, advertising, publishing, and strategy.

Katie’s editorial art appears weekly in The Cancer Letter and has been recognized by the Washington, DC Professional Chapter of the Society of Professional Journalists in 2018 and 2019, winning a total of four awards. Her work has also appeared in The Huffington Post.

Katie holds a BA from the University of Chicago (2012) and an MFA from the University of North Carolina School of the Arts (2016). She comes to management from a past career in theater, where the deadlines are even more intense than breaking news.

She has written for The Cancer Letter only once: Jerry D. Boyd, founding editor of The Cancer Letter, pioneer of cancer journalism, dies at 91